Switch to:

Telo Genomics EV-to-EBITDA

: -7.59 (As of Today)
View and export this data going back to 2016. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Telo Genomics's enterprise value is $6.33 Mil. Telo Genomics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 was $-0.83 Mil. Therefore, Telo Genomics's EV-to-EBITDA for today is -7.59.

OTCPK:TDSGF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -72.43   Med: 0   Max: 0.09
Current: -6.54

-72.43
0.09

During the past 8 years, the highest EV-to-EBITDA of Telo Genomics was 0.09. The lowest was -72.43. And the median was 0.00.

OTCPK:TDSGF's EV-to-EBITDA is ranked lower than
99.99% of the 116 Companies
in the Medical Diagnostics & Research industry.

( Industry Median: 24.75 vs. OTCPK:TDSGF: -6.54 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-09-26), Telo Genomics's stock price is $0.16. Telo Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was $-0.06. Therefore, Telo Genomics's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Telo Genomics EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Telo Genomics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Jun17 Jun18 Jun19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only 1.21 -8.08 -2.52 -2.28 -3.19

Telo Genomics Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.75 -3.19 -4.41 -3.14 -3.52

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Telo Genomics EV-to-EBITDA Distribution

* The bar in red indicates where Telo Genomics's EV-to-EBITDA falls into.



Telo Genomics EV-to-EBITDA Calculation

Telo Genomics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6.329/-0.83433544352657
=-7.59

Telo Genomics's current Enterprise Value is $6.33 Mil.
Telo Genomics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2020 was -0.10986530212958 (Jun. 2019 ) + -0.092138056038064 (Sep. 2019 ) + -0.41385071000076 (Dec. 2019 ) + -0.21848137535817 (Mar. 2020 ) = $-0.83 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Telo Genomics  (OTCPK:TDSGF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Telo Genomics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.16/-0.05849552733438
=

Telo Genomics's share price for today is $0.16.
Telo Genomics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was -0.022575062081421 (Jun. 2019 ) + -0.0075522996752511 (Sep. 2019 ) + -0.022780773027565 (Dec. 2019 ) + -0.0055873925501433 (Mar. 2020 ) = $-0.06.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Telo Genomics EV-to-EBITDA Related Terms


Telo Genomics EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)